Longaeva Partners’s Lumexa Imaging Holdings LMRI Stock Holding History

Longaeva Partners’s Portfolio LMRI Stock Details LMRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.96M	Sell	528,801 -28,622	-5%	-$261K	0.13%	156
2026 Q1	$4.79M	Buy	557,423 +357,423	+179%	+$4.91M	0.18%	112
2025 Q4	$3.7M	Buy	+200,000	New	+$3.61M	0.31%	75

Other funds holding LMRI

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Think Investments San Francisco, California $847M AUM 88.1% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

Longaeva Partners's LMRI Position: Q2 2026 in Review

Longaeva Partners reduced its Lumexa Imaging Holdings (LMRI) stake by 5.1% in Q2 2026, selling an estimated $261K and leaving 528,801 shares worth $5.96M. The position accounts for 0.13% of the portfolio, ranked #156.

Longaeva Partners first reported a position in LMRI in Q4 2025 and has held it in 3 quarters since. 102 funds tracked by Wall St. Rank hold LMRI as of Q2 2026.

Longaeva Partners held 528,801 shares of Lumexa Imaging Holdings worth $5.96M as of Q2 2026.
Longaeva Partners sold 28,622 Lumexa Imaging Holdings shares in Q2 2026, an estimated $261K.
Lumexa Imaging Holdings made up 0.13% of Longaeva Partners's portfolio in Q2 2026, its #156 holding.
Longaeva Partners first reported a position in Lumexa Imaging Holdings in Q4 2025 and has held it in 3 quarters since.
102 funds tracked by Wall St. Rank held Lumexa Imaging Holdings as of Q2 2026.

Based on Longaeva Partners's 13F filing for Q2 2026, filed 14 Aug 2026.